F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals.
0
Tag Archives: your-feed-healthcare
New California Variant More Contagious, Two Studies Confirm
Two studies confirm that a new coronavirus mutant in California is more contagious, although the scale of its threat is unclear.
0
Vaccines Adapted for Variants Will Not Need Lengthy Testing, F.D.A. Says
The agency’s new guidance will speed the development of vaccines that protect against more contagious variants of the coronavirus.
0
Who Will Be the Next F.D.A. Chief?
Two leading contenders generate wider debate about the leadership needed to restore morale and scientific integrity to an agency battered by the politicized Trump administration.
0
‘I Am Worth It’: Why Thousands of Doctors in America Can’t Get a Job
Medical schools are producing more graduates, but residency programs haven’t kept up, leaving thousands of young doctors “chronically unmatched” and deep in debt.
0
Clinical Trials Are Moving Out of the Lab and Into People’s Homes
After the pandemic forced thousands of trials to shut down, researchers found clever ways to conduct human studies remotely — while reaching more people, quickly and cheaply.
0
C.D.C. Announces $200 Million ‘Down Payment’ to Track Virus Variants
Scientists say the new investment will help in the next couple of months, but hope that the stimulus package will provide much more.
0
Some Teens Volunteer for Covid Vaccine Trials to Get Their Lives Back
Immunizing teenagers is a critical part of slowing the pandemic and reaching herd immunity. But enrolling them in clinical trials poses challenges that are very different than wrangling adults.
0
7 Virus Variants Found in U.S. Carrying the Same Mutation
Scientists don’t know yet whether the mutation makes the variants more contagious, but they are concerned that it might.
0
Scientists Are Trying to Spot New Viruses Before They Cause Pandemics
Scientists want to build a weather system for viruses. It would require a big financial investment, plus buy-in from doctors, hospitals and blood banks.
0
How Scientists Are Trying to Spot New Viruses Before They Cause Pandemics
Scientists want to build a weather system for viruses. It would require a big financial investment, plus buy-in from doctors, hospitals and blood banks.
0
W.H.O. Researcher on His Trip to China Seeking Virus Origins
An interview with Peter Daszak, an animal disease specialist, just after his return from an investigative research mission to Wuhan, the site of the original Covid outbreak, and surrounding areas.
0
As Millions Get Covid Vaccine Shots, F.D.A. Struggles With Safety Monitoring
For now, the government has been relying on a patchwork of programs that officials say are hampered by limited size and gaps in data collection.
0
Primary Care Doctors Feel Left Out of Vaccine Rollout
In the rush to immunize people against Covid, federal and state health officials have overlooked the role of doctors, physicians say.
0
How Merck’s Vaccine Lost the Covid Race
After ending its own Covid-19 vaccine trials, the company said that it is actively discussing with governments how to help its competitors make their shots.
0
How Dentistry Adapted to Covid-19: Less Drilling, Less Germ Spray
The pandemic has forced dentists and hygienists to change some of the methods for maintaining good oral hygiene, to protect patients as well as themselves.
0
Could a Single Vaccine Work Against All Coronaviruses?
Scientists are working on a shot that could protect against Covid-19, its variants, certain seasonal colds — and the next coronavirus pandemic.
0
A Few Covid Vaccine Recipients Developed a Rare Blood Disorder
A link to the vaccines is not certain, and investigations are underway in some reported cases.
0
Covid Crossroads: The Haves, Have-nots and Those Waiting
Frustration and at times resentment among those struggling to get a shot, and tempered elation on the other side of the divide.
0
Virus Variant First Found in Britain Now Spreading Rapidly in U.S.
A new study bolsters the prediction by the Centers for Disease Control and Prevention that the so-called B.1.1.7 variant will dominate Covid-19 cases by March.
0
In Line for Vaccination, and Not Getting Younger
Residents and workers at long-term-care facilities are high-priority candidates for the Covid-19 vaccines. But many are still waiting.
0
The Coronavirus Is a Master of Mixing Its Genome, Worrying Scientists
New studies underscore how coronaviruses frequently mix their genetic components — which could contribute to the rise of dangerous variants.
0
How New Vaccine News Gives Hope for Spring, if Enough People Get the Shots
New data from several vaccine trials offer positive signs, but many public health experts say emerging variants mean the next few months will be a race against the virus.
0
Even in Poorer Neighborhoods, the Wealthy Are Lining Up for Vaccines
Officials acknowledge that the coveted shots are disproportionately going to white people and that planners’ efforts to course-correct are having limited effect.
0
Have You Had Covid-19? Study Says You May Need Only One Vaccine Dose
People who have already been sick with Covid-19 should still be vaccinated, experts say, but they may experience intense side effects even after one dose.
0
Pregnant Women May Receive Covid Vaccines Safely, W.H.O. Says
The change aligns the organization with the guidance from the U.S. Centers for Disease Control and Prevention.
0
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead
Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people — and doctors have woefully few drugs with which to treat them.
0
Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease
Infectious disease doctors say getting a shot of the J&J vaccine, which has a lower efficacy against the virus than other vaccines, would still be well worthwhile.
0
Health Care Unions Find a Voice as the Pandemic Rages
Faced with the urgent need to protect their members and patients from the virus, labor organizations are pushing hospitals to do more.
0
Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants
The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases.
0
Pregnant Women Get Conflicting Advice on Covid-19 Vaccines
The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.
0
To Promote Vaccines, New Orleans Dances With Its Sleeves Rolled Up
The new, upbeat ‘Sleeves Up, NOLA’ campaign deftly uses local personalities and the Carnival dance culture to encourage citizens to get a Covid shot.
0
In Crises, Vaccines Can Be Stretched, but Not Easily
Shortages of shots for yellow fever, polio and other diseases have led to innovative solutions even in very poor countries.
0
Filing Suit for ‘Wrongful Life’
More Americans are writing end-of-life instructions as the pandemic renders such decisions less abstract. But are medical providers listening?
0
Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
0
Pfizer Will Ship Fewer Vaccine Vials to Account for ‘Extra’ Doses
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
0
Why Biden Inherited a Covid-19 Vaccine Supply Unlikely to Grow Before April
But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.
0
Biden Inherits a Vaccine Supply Unlikely to Grow Before April
But with 200 million doses pledged for the first quarter of the year, some experts say President Biden’s plan for 100 million shots in 100 days is far too modest.
0
U.S. Vaccine Supply: What to Know
Can President Biden really boost production? Why are governors trying to buy directly from Pfizer? And when will supply exceed demand?
0
Hahn Resigns as F.D.A. Commissioner; Woodcock Named Interim Chief
The Biden administration has yet to name a permanent chief of the Food and Drug Administration, amid a deep review of potential treatments and vaccines against the coronavirus.
0
New California Variant May Be Driving Virus Surge There, Study Suggests
Researchers found that the variant originated in California and showed up in more than half of samples tested last week by researchers in Los Angeles.
0
Some Medical Students Wait in Line for Covid Vaccine, While Others Share Selfies of Shots
Across states and schools, medical students’ access to the coronavirus vaccine has varied widely, creating some confusion and stress.
0
Johnson & Johnson Expects Vaccine Results Soon but Lags in Production
The U.S. needs J.&J.’s one-shot vaccine more than ever. But the company is behind on manufacturing promises made in its Operation Warp Speed contract.
0
Doctor’s Death After Getting the Covid Vaccine Is Investigated
A Florida physician developed an unusual blood disorder shortly after he received the Pfizer vaccine. It is not yet known if the shot is linked to the illness.
0
Pressure Grows for States to Open Vaccines to More Groups of People
Some states are already expanding eligibility to people 65 and over, even though millions of people the C.D.C. recommends go first — health care workers and nursing home residents — have yet to get shots.
0
False Reports of a New ‘U.S. Variant’ Came from White House Task Force
Reports of a highly contagious new variant, published on Friday by multiple news outlets, were based on speculative statements made by Dr. Deborah Birx.
0
6 Months Later, Covid Survivors Plagued by Health Problems
A large study of patients from a Wuhan, China hospital showed that a half-year later, three-quarters were struggling with problems like fatigue, depression and diminished lung function.
0
Pfizer Says Its Covid Vaccine Works Against Key Mutation
It’s good news, but experts cautioned that the new variants from Britain and South Africa also carry other potentially dangerous mutations that have not yet been investigated.
0
Covid Deaths Lowered in Trial of Tocilizumab and Sarilumab
The big dip in mortality shown in the trial of about 800 patients has caught some experts by surprise because previous studies of the drugs showed little benefit.
0
U.S. Is Blind to Contagious New Virus Variant, Scientists Warn
It’s not too late to curb the contagious variant’s spread in the U.S., experts say — but only with a national program for genetic sequencing.
0